Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Cardiotoxicity × Carvedilol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Hematologic Neoplasms 1 Cardiotoxicity 1 Breast Neoplasms, Male 1

Interventions

Exercise 2 Trastuzumab 1 Reverse Transcriptase Polymerase Chain Reaction 1 Paclitaxel 1 Mass Spectrometry 1 Magnetic Resonance Spectroscopy 1 Lisinopril 1 Lapatinib 1 Gene Expression Profiling 1 Fluorophotometry 1 Exercise Test 1 Doxorubicin 1 Cyclophosphamide 1 Chemotherapy, Adjuvant 1 Carvedilol 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01009918 2021-03-30

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

University of South Florida

Phase 2 Completed

468 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡